Oncternal Therapeutics ONCT

Quarterly report 2024-Q3
added 11-06-2024

Oncternal Therapeutics DIO Ratio 2011-2026 | ONCT

Annual DIO Ratio Oncternal Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	-	-	55.7

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
55.7	55.7	55.7

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Alnylam Pharmaceuticals ALNY	43.5	$ 330.34	3.6 %	$ 43.3 B	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aquestive Therapeutics AQST	120	$ 4.09	-0.97 %	$ 437 M	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	Arcutis Biotherapeutics ARQT	185	$ 23.66	0.11 %	$ 3.01 B	USA
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	bluebird bio BLUE	125	-	-	$ 546 M	USA
	Ardelyx ARDX	989	$ 5.97	0.51 %	$ 1.44 B	USA
	CASI Pharmaceuticals CASI	47.4	-	-	$ 35.4 M	USA